Literature DB >> 27033572

[Treatment and outcome of recurrent cervical lymph nodes in patients with nasopharyngeal carcinoma after radiotherapy].

Yongli Wang1, Guiping Lan1, Yongfeng Si1, Zhuoxia Deng1, Jinjie Sun1, Yong Yang1, Xing Han1, Jingjin Weng1, Fuling Zhou1.   

Abstract

OBJECTIVE: To evaluate the efficacies of different treatments for recurrent cervical lymph nodes and the factors contributing to prognosis in patients with nasopharyngeal carcinoma after radiotherapy.
METHODS: Clinical data of 79 patients with nasopharyngeal carcinoma after radiotherapy were retrospectively analyzed, and all cases were diagnosed as having recurrent cervical lymph nodes by pathological examination. The factors including sex, age, the interval between completion of radiotherapy and recurrence, rN stage, treatment methods, and the location relationship between recurrent lesion and primary tumor in the neck were analyzed for prognosis. Kaplan-Meier curves, Log-rank test and Cox's proportional hazards regression mode were used in the statistical analysis.
RESULTS: The median recurrence time was 26 months, and the 1- , 3- and 5-year overall survival rates were 77.9%, 53.4% and 39.7%. Cox's proportional hazards regression mode analysis indicated that age, rN stage, treatment methods, and the location relationship between recurrent lesion and primary tumor were significantly prognostic factors.
CONCLUSIONS: Neck dissection is superior to re-radiotherapy in treatment of recurrent cervical lymph nodes in nasopharyngeal carcinoma after radiotherapy. The patients younger than 45 years old, in early rN stage and for recurrence in the center region of primary tumor have a better prognosis.

Entities:  

Mesh:

Year:  2016        PMID: 27033572     DOI: 10.3760/cma.j.issn.1673-0860.2016.03.006

Source DB:  PubMed          Journal:  Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi        ISSN: 1673-0860


  2 in total

1.  Combined effects of Lenvatinib and iodine-131 on cell apoptosis in nasopharyngeal carcinoma through inducing endoplasmic reticulum stress.

Authors:  Guoyu Wang; Juhua Zhuang; Jing Ni; Ying Ye; Saifei He; Wei Xia
Journal:  Exp Ther Med       Date:  2018-08-23       Impact factor: 2.447

2.  Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways.

Authors:  Bin Zhang; Feng Tao; Hao Zhang
Journal:  Mol Med Rep       Date:  2018-02-01       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.